Hydroxychloroquine Use Is Associated with a Lower Risk of Major Adverse Cardiovascular Events in Medicare Recipients with Rheumatoid Arthritis

被引：0
|
作者：
Iyer, Priyanka [1 ]
Gao, Yubo [2 ]
Girotra, Saket [2 ]
Curtis, Jeffrey [3 ]
Vaughan-Sarrazin, Mary [1 ]
Singh, Namrata [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1891
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
    Mal, Kheraj
    Kumar, Ratan
    Mansoor, Farah
    Kaur, Navneet
    Kumar, Anil
    Memon, Sidra
    Rizwan, Amber
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [2] Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis
    Karpouzas, George Athanasios
    Ormseth, Sarah R.
    van Riel, Piet Leonardus Cornelis Maria
    Gonzalez-Gay, Miguel A.
    Corrales, Alfonso
    Rantapaa-Dahlqvist, Solbritt
    Sfikakis, Petros P.
    Dessein, Patrick
    Tsang, Linda
    Hitchon, Carol
    El-Gabalawy, Hani
    Pascual-Ramos, Virginia
    Contreras-Yanez, Irazu
    Colunga-Pedraza, Iris J.
    Galarza-Delgado, Dionicio Angel
    Azpiri-Lopez, Jose Ramon
    Semb, Anne Grete
    Misra, Durga Prasanna
    Hauge, Ellen-Margrethe
    Kitas, George
    RMD OPEN, 2024, 10 (03):
  • [3] Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients
    Sharma, Tarun S.
    Wasko, Mary Chester M.
    Tang, Xiaoqin
    Vedamurthy, Deepak
    Yan, Xiaowei
    Cote, Jonida
    Bili, Androniki
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01):
  • [4] Major Adverse Cardiovascular Events Are More Common in Rheumatoid Arthritis Than in Psoriatic Arthritis and Are Associated with Different Risk Factors
    Anandarajah, Allen P.
    Saunders, Katherine C.
    Reed, George W.
    Onofrei, Alina U.
    Greenberg, Jeffrey D.
    Ritchlin, Christopher T.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S940 - S940
  • [5] Severe adverse events with hydroxychloroquine in rheumatoid arthritis
    Reactions Weekly, 2020, 1820 (1) : 12 - 12
  • [6] Risk Factors for Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients Treated with Tocilizumab
    Rao, Vijay
    Pavlov, Andrey
    Klearman, Micki
    Musselman, David
    Giles, Jon T.
    Bathon, Joan M.
    Sattar, Naveed
    Lee, Janet S.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S642 - S642
  • [7] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Rao, Vijay
    Pavlov, Andrey
    Klearman, Micki
    Musselman, Dave
    Giles, Jon
    Bathon, Joan
    Sattar, Naveed
    Lee, Janet
    RHEUMATOLOGY, 2012, 51 : 138 - 138
  • [8] Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
    Andres Cordova Sanchez
    Farzam Khokhar
    Danielle A. Olonoff
    Robert L. Carhart
    Cardiovascular Drugs and Therapy, 2024, 38 : 297 - 304
  • [9] Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
    Sanchez, Andres Cordova
    Khokhar, Farzam
    Olonoff, Danielle A.
    Carhart, Robert L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 297 - 304
  • [10] Risk of major adverse cardiovascular events in patients with rheumatoid arthritis using Janus Kinase inhibitors
    You, Seung-Hun
    Cho, Soo-Kyung
    Song, Yeo-Jin
    Sung, Yoon-Kyoung
    Jung, Sun-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 521 - 522
12345